The case for targeting latent and lytic Epstein-Barr virus infection in multiple sclerosis - Poll - MDSpire

The case for targeting latent and lytic Epstein-Barr virus infection in multiple sclerosis

  • By

  • Gavin Giovannoni

  • Louisa James

  • Adekunle A Adeniran

  • Julian Gold

  • Lawrence S Young

  • David L Selwood

  • David Baker

  • Ruth Dobson

  • May 6, 2025

  • 0 min

Share

Original Source(s)

The case for targeting latent and lytic Epstein-Barr virus infection in multiple sclerosis

  • by Gavin Giovannoni, Louisa James, Adekunle A Adeniran, Julian Gold, Lawrence S Young, David L Selwood, David Baker, Ruth Dobson

  • May 6, 2025

Related Content

CSF Proteomics Identifies New Biomarkers for Multiple Sclerosis

Large-cohort CSF proteomics from the Mann Lab identifies a 22-protein panel distinguishing MS from related diseases

  • March 11, 2026

  • 3 min
Bile acid metabolomics reveals distinct immunometabolic niches and enables accurate diagnosis of AQP4-IgG–seronegative NMOSD

Associations of Serum Alpha-Linolenic Acid with Disability and Brain Volume in Multiple Sclerosis: A Concise Replication Study